Oliver Luxxe Assets’s Labcorp LH Stock Holding History

Oliver Luxxe Assets’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,858	Closed	-$2.39M	–	206
2021 Q4	$2.39M	Buy	8,858 +6	+0.1%	+$1.49K	0.61%	64
2021 Q3	$2.14M	Buy	+8,852	New	+$2.23M	0.59%	65

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oliver Luxxe Assets's LH Position: Q1 2022 in Review

Oliver Luxxe Assets sold out of Labcorp (LH) in Q1 2022, closing a stake of 8,858 shares — an estimated $2.39M sold.

Oliver Luxxe Assets first reported a position in LH in Q3 2021 and held it in 2 quarters. The position peaked at $2.39M in Q4 2021. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

Oliver Luxxe Assets reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
Oliver Luxxe Assets sold 8,858 Labcorp shares in Q1 2022, an estimated $2.39M.
Oliver Luxxe Assets first reported a position in Labcorp in Q3 2021 and held it in 2 quarters.
Oliver Luxxe Assets's Labcorp position peaked at $2.39M in Q4 2021.
1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Oliver Luxxe Assets's 13F filing for Q1 2022, filed 13 May 2022.